Coronary atherosclerosis of the diabetic;L'athérosclérose coronaire du diabétique

Archives des Maladies du Coeur et des Vaisseaux

Volumn 93, Issue SPEC. ISS IV, 2000, Pages 19-24

  Steg, Ph G ^a   Karila Cohen, D ^a   Feldman, L J ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; RISK FACTOR; WORLD HEALTH ORGANIZATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; COLLATERAL CIRCULATION; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; GRAFT OCCLUSION, VASCULAR; HOSPITALIZATION; HUMANS; HYPERPLASIA; MYOCARDIAL INFARCTION; RISK; SURVIVAL RATE; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 0034517283     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial
2. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study
3. Vascular complications of diabetes
4. Maladie coronaire chez le diabéque et risque d'infarctus du myocarde
5. Effect of diabetes mellitus on formation of coronary collateral vessels
6. Diabetes and decline in heart disease mortality in US adults
7. Diabetes mellitus: Biological determinants of atherosclerosis and restenosis
8. Activation of receptor for advanced glycation endproducts: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
9. Coronary angioplasty in diabetic patients. The National heart, Lung and Blood Institute Percutoneous Transluminal Coronary Angioplasty Registry
10. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease
11. Bypass surgery versus coronary angioplasty for revascularization at treated diabetic patients
12. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
13. Multivessel balloon angiolasty should be abandoned in diabetic patients!
14. Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status
15. The effect of previous coronary artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction
16. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
17. Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization?
18. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement
19. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study
20. Long-term angiographic follow-up of conorary balloon angiolasty in patients with diabetes mellitus: A clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation
21. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI)
22. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors
23. Abciximab reduces mortality in diabetics following percutaneaus coronary intervention
24. Optimizing the percutoneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy
25. Indications for fibrinolytic therapy in suspected acute myocardial, infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
26. Influence of diabetes mellitus on clinical outcome in the thrombolytic ara of acute myocardial infarction
27. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction
28. Impact of early reperfusion therapy on patency and survival iri diabetic vs nondiabetic patients with acute myocardial infarction
29. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
30. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium